Zhen-guo Liu
1665 Kongjiang Road
Shanghai, 200092, China
Shanghai, 200092, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Autonomic function and motor subtypes in Parkinson's disease: a multicentre cross-sectional study.
Journal: Scientific reports
Published: June 26, 2022
Naoxintong Capsule for Secondary Prevention of Ischemic Stroke: A Multicenter, Randomized, and Placebo-Controlled Trial.
Journal: Chinese journal of integrative medicine
Published: June 07, 2022
Pingchan Granule for Motor Symptoms and Non-Motor Symptoms of Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study.
Journal: Frontiers in pharmacology
Published: July 10, 2021
The Phenotypic and Genetic Spectrum of Paroxysmal Kinesigenic Dyskinesia in China.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: August 21, 2019
Antidyskinetic Treatment with MTEP Affects Multiple Molecular Pathways in the Parkinsonian Striatum.
Antidyskinetic Treatment with MTEP Affects Multiple Molecular Pathways in the Parkinsonian Striatum.
Journal: Parkinson's disease
Published: February 17, 2017
Current Experimental Studies of Gene Therapy in Parkinson's Disease.
Journal: Frontiers in aging neuroscience
Published: October 31, 2016
Lipoic acid alleviates L‑DOPA‑induced dyskinesia in 6‑OHDA parkinsonian rats via anti‑oxidative stress.
Journal: Molecular medicine reports
Published: April 28, 2016
Inhibition of Glycogen Synthase Kinase-3β (GSK-3β) as potent therapeutic strategy to ameliorates L-dopa-induced dyskinesia in 6-OHDA parkinsonian rats.
Journal: Scientific reports
Published: December 11, 2015
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis.
Journal: Journal of molecular neuroscience : MN
Published: July 13, 2015
A systematic review and meta-analysis of Ginsenoside-Rg1 (G-Rg1) in experimental ischemic stroke.
Journal: Scientific reports
Published: October 31, 2014
Prevalence of wearing-off and dyskinesia among the patients with Parkinson's disease on levodopa therapy: a multi-center registry survey in mainland China.
Journal: Translational neurodegeneration
Published: October 13, 2014
Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats.
Journal: Scientific reports
Published: September 14, 2014
Last Updated: 09/26/2026